Medical News

RSS

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

A team of international scientists has developed an mRNA-based coronavirus disease 2019 (COVID-19) vaccine encoding the receptor-binding domain (RBD) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) delta variant. The vaccine candidate has shown high efficacy in inducing neutralizing antibodies and protecting against delta infection in mice. The study is currently available on the bioRxiv* preprint server.

24 Mar 2022

Physical activity boosts cognitive performance in middle-aged and older adults, study shows

A new study by researchers at The University of California San Diego School of Medicine adds to the canon of research associating physical activity with cognitive performance, this time using 90 middle-aged and older participants who wore accelerometers while physically active and completed mobile cognitive testing from home.

24 Mar 2022

Extensive immediate actions needed for global control of tuberculosis

Announcing a new article publication for Zoonoses journal. In this article the authors discuss how extensive immediate actions worldwide are required to progress toward a tuberculosis-free world.

24 Mar 2022

Adverse health effects of micro- and nanoplastic particles in food

Five grams of plastic particles on average enter the human gastrointestinal tract per person per week. This is roughly equivalent to the weight of a credit card.

24 Mar 2022

IgG Fc glycosylation: A marker for severe COVID-19

Researchers suggest that low anti-spike IgG1 glycosylation, sialyation, and high bisection are markers of severe COVID-19.

24 Mar 2022

The intercontinental spread of high-pathogenic avian influenza A (H5N1) virus

Researchers aim to better understand the landscape movement of the avian influenza virus.

24 Mar 2022

Brain fog in post-COVID Canadians

A new study confirms that a history of COVID-19 is a risk factor for cognitive dysfunction in the young and middle-aged.

24 Mar 2022

Breast milk components show potent in vitro SARS-CoV-2 inhibition

Human breastmilk contains substances that can inhibit infection by SARS-CoV-2 and its variants, as well as prevent its replication.

24 Mar 2022

Shorter course of antibiotics associated with fewer antibiotic resistance genes

Antibiotic resistance is a growing problem worldwide that threatens the efficacy of available treatments and can lead to extended hospital stays and increased mortality.

24 Mar 2022

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

Researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed an implantable biotechnology that produces and releases CAR-T cells for attacking cancerous tumors.

24 Mar 2022

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

Tuberculosis (TB) is a potentially serious infectious disease caused by a type of bacterium called Mycobacterium tuberculosis.

24 Mar 2022

Spinal fluid sampling could provide data about tumors sooner than MRIs

Treatment for glioma has long relied on MRI imaging to track tumor markers and treatment response.

24 Mar 2022

Older people taking statins have lower chance of developing parkinsonism later, study suggests

Parkinsonism is a term for a group of neurological conditions that cause movement problems including tremors, slowed movement and stiffness, with Parkinson's disease being one of the better knowns causes.

24 Mar 2022

INRS professor developing a glycoconjugate vaccine for melioidosis

The threat from Melioidosis is real. The bacterium that causes this infectious multisymptom illness is resistant to antibiotics, making diagnosis and treatment more complex and resulting in a mortality rate of up to 50%.

24 Mar 2022

Research examines HPV-related cancer knowledge in rural communities

Shillpa Naavaal, Virginia Commonwealth University, Richmond, presented "From Cervical Cancers to Oropharyngeal: HPV Research in Rural Communities" at the hybrid 51st Annual Meeting & Exhibition of the AADOCR, held in conjunction with the 46th Annual Meeting of the Canadian Association for Dental Research, online and onsite in Atlanta, GA, on March 21-26, 2022.

24 Mar 2022

Aspirin use associated with lower rates of death in hospitalized COVID-19 patients

Researchers at the George Washington University published findings from the world's largest cohort study showing that hospitalized patients with moderate COVID-19 who were given aspirin early on in their treatment had a lower risk of dying compared to patients who were not given aspirin.

24 Mar 2022

Medical News

A novel mRNA vaccine encoding delta RBD induces high neutralizing antibody titers

Physical activity boosts cognitive performance in middle-aged and older adults, study shows

Extensive immediate actions needed for global control of tuberculosis

Adverse health effects of micro- and nanoplastic particles in food

IgG Fc glycosylation: A marker for severe COVID-19

The intercontinental spread of high-pathogenic avian influenza A (H5N1) virus

Brain fog in post-COVID Canadians

Breast milk components show potent in vitro SARS-CoV-2 inhibition

Shorter course of antibiotics associated with fewer antibiotic resistance genes

New implantable biotechnology produces and releases CAR-T cells for attacking tumors

Tuberculosis perturbs epigenetic processes to promote premature cellular aging

Spinal fluid sampling could provide data about tumors sooner than MRIs

Older people taking statins have lower chance of developing parkinsonism later, study suggests

INRS professor developing a glycoconjugate vaccine for melioidosis

Research examines HPV-related cancer knowledge in rural communities

Aspirin use associated with lower rates of death in hospitalized COVID-19 patients

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

Polio vaccination campaign kicks off in Malawi and neighboring countries

Short duration treatment effective in combating most childhood TB cases, study says

Study investigates anti-SARS-CoV-2 antibody levels following Pfizer vaccine primary and booster regimens

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News